Sarcoidosis and Beryllium-Induced Lung
Disease
Sarcoidosis
The University of Pennsylvania Health System has participated in multi-center
NIH-sponsored studies in sarcoidosis as
well as drug company-sponsored clinical trials. A multidisciplinary approach
is taken for patients with chronic sarcoidosis and difficult treatment issues.
Patients are offered state-of-the-art diagnostic facilities and cuting-edge
treatment options.
Beryllium-Induced Lung Disease
Penn is internationally recognized as a referral center for the evaluation,
diagnosis and treatment of patients with chronic beryllium disease. In addition,
our staff is available to assist industry in the development of cost-effective
screening programs for beryllium disease, and in the evaluation and treatment
of symptomatic workers.
Location
Hospital
of the University of Pennsylvania
3 Ravdin, Suite F
3400 Spruce Street
Philadelphia, PA 19104
Driving Directions
|
